author-photo

Sarah-Jayne Reilly

Hoffmann-La Roche

2

Papers

0

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)